Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The Current Status of Allogenic Islet Cell Transplantation

10 Oct 2023

Abstract excerpt

Type 1 Diabetes (T1D) is an autoimmune destruction of pancreatic beta cells. The development of the Edmonton Protocol for islet transplantation in 2000 revolutionized T1D treatment and offered a glimpse at a cure for the disease. In 2022, the 20-year follow-up findings of islet cell transplantation demonstrated the long-term safety of islet cell transplantation despite chronic immunosuppression. The Edmonton...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Pancreatic function and diabetes
Share to Pluripotent Stem Cells Research

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 37887267
DOI: 10.3390/cells12202423

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The Current Status of Allogenic Islet Cell TransplantationPMID 37887267Read ↗

Towards a Functional Cure for Diabetes Using Stem Cell-Derived Beta Cells: Are We There Yet?Semantic proximity Read ↗

Novel Treatment Modalities of Type 1 Diabetes Mellitus: Opportunities and ChallengesSemantic proximity Read ↗

The potential and challenges of alternative sources of β cells for the cure of type 1 diabetesSemantic proximity Read ↗

Applications of iPSC-derived beta cells from patients with diabetesSemantic proximity Read ↗

A perfect islet: reviewing recent protocol developments and proposing strategies for stem cell derived functional pancreatic isletsSemantic proximity Read ↗

Stem cells as a therapeutic target for diabetesSemantic proximity Read ↗

Stem cell-derived pancreatic beta cells: a step closer to functional diabetes treatment?Semantic proximity Read ↗

Characterization of stem-cell-derived islets during differentiation and after implantationSemantic proximity Read ↗

Islet organoid as a promising model for diabetesSemantic proximity Read ↗

Stem cell approaches for diabetes: towards beta cell replacementSemantic proximity Read ↗

The prospect of induced pluripotent stem cells for diabetes mellitus treatmentSemantic proximity Read ↗

iPSC technology‐based regenerative therapy for diabetesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.